Research Interests

Mechanism of action of insulin and insulin-like growth factors

I am interested in the receptors and signalling pathways that mediate the actions of insulin and IGFs, particularly molecular mechanisms underlying insulin/IGF signalling specificity and regulatory pathways impacting on insulin/IGF sensitivity. Latterly my group worked on aspects of receptor structure, particularly determinants of ligand binding affinity and specificity, and the regulatory effects of insulin/IGFs on gene transcription. I formally retired from my University position in September 2014 but retain active research interests in collaboration with colleagues: Professor Robert Semple and Dr Gemma Brierley (Therapeutic applications of anti-insulin receptor antibodies, funded by Diabetes UK) and Professor Susan Ozanne (Early life programming of insulin action, funded by BBSRC).

 

Selected Publications

Brierley, G.V., Siddle, K. & Semple, R.K. (2018) Evaluation of anti insulin receptor antibodies as potential novel therapies for human insulin receptoropathy. Diabetologia (in press)

Groeneveld, M.P., Brierley, G.V., Rocha, N.M., Siddle, K. & Semple, R.K. (2016) Acute knockdown of the insulin receptor or its substrates Irs1 and 2 in 3T3-L1 adipocytes suppresses adiponectin production. Sci Rep, 6:21105. PMID: 26888756.  PMCID: PMC4758029.

Martin-Gronert MS, Fernandez-Twinn DS, Bushell M, Siddle K, Ozanne SE.  (2016) Cell-autonomous programming of rat adipose tissue insulin signalling proteins by maternal nutrition.  Diabetologia, 59(6): 1266-75. PMID: 26965244.  PMCID: PMC4861755.

Siddle, K. (2012) Molecular basis of signaling specificity of insulin and IGF receptors: neglected corners and recent advances.  Front Endocrinol, 3:34.  PMID: 22649417.PMCID: PMC3355962.

Ferland-McCollough, D., Fernandez-Twinn, D.S., Cannell, I.G., David, H., Warner, M., Vaag, A.A., Bork-Jensen, J., Brøns, C., Gant, T.W., Willis, A.E., Siddle, K., Bushell, M. & Ozanne, S.E. (2012) Programming of miR-483-3p and GDF-3 expression by maternal diet in type 2 diabetes.  Cell Death Differ, 19(6): 1003-12.  PMID: 22223106. PMCID: PMC3354052